CREM and neoplasm: Using immunoblotting, we revealed that more Crem protein isoforms and at higher levels were expressed in tumors than in matched non-tumor liver tissues, reaching the highest levels in tumors having genomic Crem amplifications (FC>1.5; Figure 6A).